Financial Summary (All financials)
| In millions, except per share items | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| Revenues | 27.2 | 41.0 | 8.0 | 5.0 | 1.3 |
| Revenue growth | -33.7% | 410.6% | 60.1% | 277.1% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 2.3 |
| Gross profit | 27.2 | 41.0 | 8.0 | 5.0 | -1.0 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | -72.2% |
| Research and development | 69.0 | 49.5 | 23.3 | 23.0 | |
| General and administrative | 15.4 | 11.3 | 5.4 | 4.1 | 2.3 |
| EBIT | -57.2 | -19.8 | -20.7 | -22.2 | -21.0 |
| EBIT margin | -210.5% | -48.4% | -257.6% | -441.9% | -1582.4% |
| Pre-tax income | -53.9 | -18.3 | -23.9 | -22.7 | -20.8 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -53.9 | -18.3 | -23.9 | -22.7 | 0.0 |
| Net margin | -198.4% | -44.5% | -297.3% | -452.7% | -1.6% |
| |
| Diluted EPS | ($1.42) | ($0.69) | ($2.36) | ($31.11) | ($40.19) |
| Shares outstanding (diluted) | 38.1 | 26.5 | 10.1 | 0.7 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|